(0)サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1642421

治療用アフェレシスの世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2032年）

Therapeutic Apheresis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032

出版日
ページ情報
英文 178 Pages
納期
2～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.87円
治療用アフェレシスの世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2032年）
出版日: 2025年01月24日
発行: Fairfield Market Research
ページ情報: 英文 178 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

治療用アフェレシスの市場規模は、医療技術の進歩と精密医療の統合の進展に後押しされ、著しい拡大が見込まれています。CAGRは7.3%で、2025年には32億2,000万米ドルに達し、2032年には53億米ドルに拡大すると予測されています。

治療用アフェレシスとは、血流から有害物質を選択的に除去する医療プロセスであり、自己免疫疾患、神経疾患、血液関連疾患など様々な疾患の治療に役立ちます。医療機器の革新と並んで、これらの疾患の有病率の増加が市場成長に大きく寄与しています。治療用アフェレシス市場は、技術の進歩、疾患有病率の上昇、精密医療の採用拡大により、大きく拡大する見込みです。主要企業が研究開発に投資していることから、この業界は今後数年で大きく成長する態勢を整えています。

自動アフェレシスシステムと膜ベースのろ過技術の採用により、治療の効率性、安全性、精度が向上しています。自己免疫疾患や血液疾患の増加により、治療用アフェレシスに対する需要が高まっています。アフェレーシスで治療可能な疾患にかかりやすい高齢者の増加が市場拡大を促進しています。アフェレーシスの利点に関する医療従事者の認知度の向上が、その普及を促進しています。

当レポートでは、世界の治療用アフェレシス市場について調査し、市場の概要とともに、手技タイプ別、技術別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナ・ロシア紛争の影響
  • 経済概要
  • PESTLE分析

第3章 価格分析、2019年～2023年

第4章 世界の治療用アフェレーシス市場の見通し、2019年～2032年

  • 2019年～2032年の世界の治療用アフェレーシス市場の見通し、手技タイプ別、金額（10億米ドル）、数量（箱）
  • 2019年～2032年の世界の治療用アフェレーシス市場の見通し、技術別、金額（10億米ドル）、数量（箱）
  • 2019年～2032年の世界の治療用アフェレーシス市場の見通し、用途別、金額（10億米ドル）、数量（箱）
  • 2019年～2032年の世界の治療用アフェレーシス市場の見通し、エンドユーザー別、金額（10億米ドル）、数量（箱）
  • 2019年～2032年の世界の治療用アフェレーシス市場の見通し、地域別、金額（10億米ドル）、数量（箱）

第5章 北米の治療用アフェレーシス市場の見通し、2019年～2032年

第6章 欧州の治療用アフェレーシス市場の見通し、2019年～2032年

第7章 アジア太平洋の治療用アフェレーシス市場の見通し、2019年～2032年

第8章 ラテンアメリカの治療用アフェレーシス市場の見通し、2019年～2032年

第9章 中東・アフリカの治療用アフェレーシス市場の見通し、2019年～2032年

第10章 競合情勢

  • 手技タイプ別vs技術別ヒートマップ
  • 企業市場シェア分析、2024年
  • 競合ダッシュボード
  • 企業プロファイル
    • Asahi Kasei Medical Co.
    • Haemonetics Corporation
    • Miltenyi Biotec
    • Cerus Corporation
    • Terumo BCT Inc.
    • Fresenius Kabi USA
    • Terumo BCT
    • B. Braun Melsungen AG
    • Nikkiso Co. Ltd.
    • Medica S.p.A.
    • Baxter Healthcare Corporation
    • Kawasumi Laboratories Inc.
    • Therakos Incorporation

第11章 付録

目次

The therapeutic apheresis market is on track for remarkable expansion, propelled by advancements in medical technology and the growing integration of precision medicine. With an anticipated CAGR of 7.3%, the market is projected to reach USD 3.22 billion by 2025 and further increase to USD 5.30 billion by 2032.

Market Overview

Therapeutic apheresis is a medical process that selectively removes harmful substances from the bloodstream, aiding in the treatment of various conditions such as autoimmune disorders, neurological ailments, and blood-related diseases. The increasing prevalence of these conditions, alongside innovations in medical equipment, is significantly contributing to market growth. The therapeutic apheresis market is set for significant expansion, driven by technological advancements, rising disease prevalence, and growing adoption of precision medicine. With major players investing in research and development, the industry is poised for transformative growth in the coming years.

Key Market Drivers

  • Advancements in Technology: The adoption of automated apheresis systems and membrane-based filtration technologies has enhanced efficiency, safety, and precision in treatment.
  • Increasing Disease Incidence: Rising cases of autoimmune and hematologic conditions are driving the demand for therapeutic apheresis procedures.
  • Aging Population: The increasing number of elderly individuals, who are more vulnerable to diseases treatable with apheresis, is fostering market expansion.
  • Growing Awareness: Greater recognition among healthcare professionals regarding the benefits of apheresis is facilitating its widespread adoption.

Emerging Business Opportunities

  • Integration into Precision Medicine: The use of therapeutic apheresis in personalized treatment plans is gaining momentum.
  • Diversification of Applications: Beyond its traditional use in hematology and neurology, apheresis is being explored for applications in oncology and rare genetic conditions.
  • Collaborative Growth: Strategic partnerships between healthcare providers, research institutions, and industry stakeholders are driving innovation and market penetration.

Regional Market Trends

  • North America: Expected to maintain the largest share, supported by advanced healthcare infrastructure, high spending on medical treatments, and rapid technological adoption.
  • Asia Pacific: Forecasted to witness the fastest growth due to increasing healthcare investments and rising awareness, especially in China and Japan.
  • Europe: A well-regulated healthcare industry continues to provide steady market expansion.
  • Other Regions (Latin America, , Middle East & Africa): Increasing demand for advanced healthcare solutions is spurring growth in these markets.

Leading Market Participants

Key companies are focusing on research, innovation, and geographical expansion to solidify their market presence. Major players include:

  • Asahi Kasei Medical Co.
  • Haemonetics Corporation
  • Miltenyi Biotec
  • Cerus Corporation
  • Terumo BCT Inc.
  • Fresenius Kabi USA
  • B. Braun Melsungen AG
  • Nikkiso Co. Ltd.
  • Medica S.p.A.
  • Baxter Healthcare Corporation
  • Kawasumi Laboratories Inc.
  • Therakos Incorporation

Recent Industry Developments

  • New Partnership: Terumo Blood and Cell Technologies collaborated with Eliaz Therapeutics to develop a novel therapeutic apheresis treatment for acute kidney injury (AKI).
  • Investment in Innovation: NHS England has approved Terumo's Spectra Optia Apheresis System for treating sickle cell disease, significantly increasing its adoption across various institutions.

Market Segmentation

By Procedure Type:

  • Therapeutic Plasma Exchange (TPE)
  • Red Blood Cell Exchange (RBCX)
  • Cellular Depletions

By Technology:

  • Centrifugation
  • Membrane Filtration

By Application:

  • Hematology
  • Neurology
  • Nephrology
  • Rheumatology
  • Oncology
  • Others

By End User:

  • Hospitals
  • Blood Banks
  • Specialty Clinics

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Therapeutic Apheresis Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Price Analysis, 2019 - 2023

  • 3.1. Global Average Price Analysis by Procedure Type, 2019 - 2023
  • 3.2. Prominent Factor Affecting Therapeutic Apheresis Prices
  • 3.3. Global Average Price Analysis by Region

4. Global Therapeutic Apheresis Market Outlook, 2019 - 2032

  • 4.1. Global Therapeutic Apheresis Market Outlook, by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Therapeutic Plasma Exchange (TPE)
      • 4.1.1.2. Red Blood Cell Exchange (RBCX)
      • 4.1.1.3. Cellular Depletions
  • 4.2. Global Therapeutic Apheresis Market Outlook, by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. Centrifugation
      • 4.2.1.2. Membrane filtration
  • 4.3. Global Therapeutic Apheresis Market Outlook, by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hematology
      • 4.3.1.2. Neurology
      • 4.3.1.3. Nephrology
      • 4.3.1.4. Rheumatology
      • 4.3.1.5. Oncology
      • 4.3.1.6. Others
  • 4.4. Global Therapeutic Apheresis Market Outlook, by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 4.4.1. Key Highlights
      • 4.4.1.1. Hospitals
      • 4.4.1.2. Blood banks
      • 4.4.1.3. Specialty clinics
  • 4.5. Global Therapeutic Apheresis Market Outlook, by Region, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 4.5.1. Key Highlights
      • 4.5.1.1. North America
      • 4.5.1.2. Europe
      • 4.5.1.3. Asia Pacific
      • 4.5.1.4. Latin America
      • 4.5.1.5. Middle East & Africa

5. North America Therapeutic Apheresis Market Outlook, 2019 - 2032

  • 5.1. North America sTherapeutic Apheresis Market Outlook, by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Therapeutic Plasma Exchange (TPE)
      • 5.1.1.2. Red Blood Cell Exchange (RBCX)
      • 5.1.1.3. Cellular Depletions
  • 5.2. North America Therapeutic Apheresis Market Outlook, by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Centrifugation
      • 5.2.1.2. Membrane filtration
  • 5.3. North America Therapeutic Apheresis Market Outlook, by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hematology
      • 5.3.1.2. Neurology
      • 5.3.1.3. Nephrology
      • 5.3.1.4. Rheumatology
      • 5.3.1.5. Oncology
      • 5.3.1.6. Others
  • 5.4. North America Therapeutic Apheresis Market Outlook, by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 5.4.1. Key Highlights
      • 5.4.1.1. Hospitals
      • 5.4.1.2. Blood banks
      • 5.4.1.3. Specialty clinics
    • 5.4.2. Attractiveness Analysis
  • 5.5. North America Therapeutic Apheresis Market Outlook, by Country, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 5.5.1. Key Highlights
      • 5.5.1.1. U.S. Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 5.5.1.2. U.S. Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 5.5.1.3. U.S. Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 5.5.1.4. U.S. Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 5.5.1.5. Canada Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 5.5.1.6. Canada Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 5.5.1.7. Canada Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 5.5.1.8. Canada Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032

6. Europe Therapeutic Apheresis Market Outlook, 2019 - 2032

  • 6.1. Europe Therapeutic Apheresis Market Outlook, by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Therapeutic Plasma Exchange (TPE)
      • 6.1.1.2. Red Blood Cell Exchange (RBCX)
      • 6.1.1.3. Cellular Depletions
  • 6.2. Europe Therapeutic Apheresis Market Outlook, by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Centrifugation
      • 6.2.1.2. Membrane filtration
  • 6.3. Europe Therapeutic Apheresis Market Outlook, by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hematology
      • 6.3.1.2. Neurology
      • 6.3.1.3. Nephrology
      • 6.3.1.4. Rheumatology
      • 6.3.1.5. Oncology
      • 6.3.1.6. Others
  • 6.4. Europe Therapeutic Apheresis Market Outlook, by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.4.1. Key Highlights
      • 6.4.1.1. Hospitals
      • 6.4.1.2. Blood banks
      • 6.4.1.3. Specialty clinics
    • 6.4.2. Attractiveness Analysis
  • 6.5. Europe Therapeutic Apheresis Market Outlook, by Country, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 6.5.1. Key Highlights
      • 6.5.1.1. Germany Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.2. Germany Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.3. Germany Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.4. Germany Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.5. U.K. Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.6. U.K. Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.7. U.K. Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.8. U.K. Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.9. France Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.10. France Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.11. France Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.12. France Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.13. Italy Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.14. Italy Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.15. Italy Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.16. Italy Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.17. Turkey Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.18. Turkey Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.19. Turkey Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.20. Turkey Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.21. Russia Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.22. Russia Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.23. Russia Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.24. Russia Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.25. Rest of Europe Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.26. Rest of Europe Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.27. Rest of Europe Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 6.5.1.28. Rest of Europe Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032

7. Asia Pacific Therapeutic Apheresis Market Outlook, 2019 - 2032

  • 7.1. Asia Pacific Therapeutic Apheresis Market Outlook, by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Therapeutic Plasma Exchange (TPE)
      • 7.1.1.2. Red Blood Cell Exchange (RBCX)
      • 7.1.1.3. Cellular Depletions
  • 7.2. Asia Pacific Therapeutic Apheresis Market Outlook, by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.2.1. Key Highlights
      • 7.2.1.1. Centrifugation
      • 7.2.1.2. Membrane filtration
  • 7.3. Asia Pacific Therapeutic Apheresis Market Outlook, by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hematology
      • 7.3.1.2. Neurology
      • 7.3.1.3. Nephrology
      • 7.3.1.4. Rheumatology
      • 7.3.1.5. Oncology
      • 7.3.1.6. Others
  • 7.4. Asia Pacific Therapeutic Apheresis Market Outlook, by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.4.1. Key Highlights
      • 7.4.1.1. Hospitals
      • 7.4.1.2. Blood banks
      • 7.4.1.3. Specialty clinics
    • 7.4.2. Attractiveness Analysis
  • 7.5. Asia Pacific Therapeutic Apheresis Market Outlook, by Country, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 7.5.1. Key Highlights
      • 7.5.1.1. China Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.2. China Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.3. China Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.4. China Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.5. Japan Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.6. Japan Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.7. Japan Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.8. Japan Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.9. South Korea Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.10. South Korea Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.11. South Korea Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.12. South Korea Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.13. India Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.14. India Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.15. India Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.16. India Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.17. Southeast Asia Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.18. Southeast Asia Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.19. Southeast Asia Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.20. Southeast Asia Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.21. Rest of Asia Pacific Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.22. Rest of Asia Pacific Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.23. Rest of Asia Pacific Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 7.5.1.24. Rest of Asia Pacific Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032

8. Latin America Therapeutic Apheresis Market Outlook, 2019 - 2032

  • 8.1. Latin America Therapeutic Apheresis Market Outlook, by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Therapeutic Plasma Exchange (TPE)
      • 8.1.1.2. Red Blood Cell Exchange (RBCX)
      • 8.1.1.3. Cellular Depletions
  • 8.2. Latin America Therapeutic Apheresis Market Outlook, by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Centrifugation
      • 8.2.1.2. Membrane filtration
  • 8.3. Latin America Therapeutic Apheresis Market Outlook, by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hematology
      • 8.3.1.2. Neurology
      • 8.3.1.3. Nephrology
      • 8.3.1.4. Rheumatology
      • 8.3.1.5. Oncology
      • 8.3.1.6. Others
  • 8.4. Latin America Therapeutic Apheresis Market Outlook, by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 8.4.1. Key Highlights
      • 8.4.1.1. Hospitals
      • 8.4.1.2. Blood banks
      • 8.4.1.3. Specialty clinics
    • 8.4.2. Attractiveness Analysis
  • 8.5. Latin America Therapeutic Apheresis Market Outlook, by Country, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 8.5.1. Key Highlights
      • 8.5.1.1. Brazil Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.2. Brazil Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.3. Brazil Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.4. Brazil Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.5. Mexico Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.6. Mexico Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.7. Mexico Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.8. Mexico Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.9. Argentina Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.10. Argentina Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.11. Argentina Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.12. Argentina Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.13. Rest of Latin America Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.14. Rest of Latin America Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.15. Rest of Latin America Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 8.5.1.16. Rest of Latin America Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032

9. Middle East & Africa Therapeutic Apheresis Market Outlook, 2019 - 2032

  • 9.1. Middle East & Africa Therapeutic Apheresis Market Outlook, by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.1.1. Key Highlights
      • 9.1.1.1. Therapeutic Plasma Exchange (TPE)
      • 9.1.1.2. Red Blood Cell Exchange (RBCX)
      • 9.1.1.3. Cellular Depletions
  • 9.2. Middle East & Africa Therapeutic Apheresis Market Outlook, by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.2.1. Key Highlights
      • 9.2.1.1. Centrifugation
      • 9.2.1.2. Membrane filtration
  • 9.3. Middle East & Africa Therapeutic Apheresis Market Outlook, by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.3.1. Key Highlights
      • 9.3.1.1. Hematology
      • 9.3.1.2. Neurology
      • 9.3.1.3. Nephrology
      • 9.3.1.4. Rheumatology
      • 9.3.1.5. Oncology
      • 9.3.1.6. Others
  • 9.4. Middle East & Africa Therapeutic Apheresis Market Outlook, by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.4.1. Key Highlights
      • 9.4.1.1. Hospitals
      • 9.4.1.2. Blood banks
      • 9.4.1.3. Specialty clinics
    • 9.4.2. Attractiveness Analysis
  • 9.5. Middle East & Africa Therapeutic Apheresis Market Outlook, by Country, Value (US$ Bn) and Volume (Box), 2019 - 2032
    • 9.5.1. Key Highlights
      • 9.5.1.1. GCC Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.2. GCC Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.3. GCC Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.4. GCC Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.5. South Africa Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.6. South Africa Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.7. South Africa Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.8. South Africa Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.9. Egypt Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.10. Egypt Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.11. Egypt Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.12. Egypt Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.13. Nigeria Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.14. Nigeria Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.15. Nigeria Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.16. Nigeria Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.17. Rest of Middle East & Africa Therapeutic Apheresis Market by Procedure Type, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.18. Rest of Middle East & Africa Therapeutic Apheresis Market by Technology, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.19. Rest of Middle East & Africa Therapeutic Apheresis Market by Application, Value (US$ Bn) and Volume (Box), 2019 - 2032
      • 9.5.1.20. Rest of Middle East & Africa Therapeutic Apheresis Market by End User, Value (US$ Bn) and Volume (Box), 2019 - 2032

10. Competitive Landscape

  • 10.1. By Procedure Type vs by Technology Heatmap
  • 10.2. Company Market Share Analysis, 2024
  • 10.3. Competitive Dashboard
  • 10.4. Company Profiles
    • 10.4.1. Asahi Kasei Medical Co.
      • 10.4.1.1. Company Overview
      • 10.4.1.2. Product Portfolio
      • 10.4.1.3. Financial Overview
      • 10.4.1.4. Business Strategies and Development
    • 10.4.2. Haemonetics Corporation
      • 10.4.2.1. Company Overview
      • 10.4.2.2. Product Portfolio
      • 10.4.2.3. Financial Overview
      • 10.4.2.4. Business Strategies and Development
    • 10.4.3. Miltenyi Biotec
      • 10.4.3.1. Company Overview
      • 10.4.3.2. Product Portfolio
      • 10.4.3.3. Financial Overview
      • 10.4.3.4. Business Strategies and Development
    • 10.4.4. Cerus Corporation
      • 10.4.4.1. Company Overview
      • 10.4.4.2. Product Portfolio
      • 10.4.4.3. Financial Overview
      • 10.4.4.4. Business Strategies and Development
    • 10.4.5. Terumo BCT Inc.
      • 10.4.5.1. Company Overview
      • 10.4.5.2. Product Portfolio
      • 10.4.5.3. Financial Overview
      • 10.4.5.4. Business Strategies and Development
    • 10.4.6. Fresenius Kabi USA
      • 10.4.6.1. Company Overview
      • 10.4.6.2. Product Portfolio
      • 10.4.6.3. Financial Overview
      • 10.4.6.4. Business Strategies and Development
    • 10.4.7. Terumo BCT
      • 10.4.7.1. Company Overview
      • 10.4.7.2. Product Portfolio
      • 10.4.7.3. Financial Overview
      • 10.4.7.4. Business Strategies and Development
    • 10.4.8. B. Braun Melsungen AG
      • 10.4.8.1. Company Overview
      • 10.4.8.2. Product Portfolio
      • 10.4.8.3. Financial Overview
      • 10.4.8.4. Business Strategies and Development
    • 10.4.9. Nikkiso Co. Ltd.
      • 10.4.9.1. Company Overview
      • 10.4.9.2. Product Portfolio
      • 10.4.9.3. Financial Overview
      • 10.4.9.4. Business Strategies and Development
    • 10.4.10. Medica S.p.A.
      • 10.4.10.1. Company Overview
      • 10.4.10.2. Product Portfolio
      • 10.4.10.3. Financial Overview
      • 10.4.10.4. Business Strategies and Development
    • 10.4.11. Baxter Healthcare Corporation
      • 10.4.11.1. Company Overview
      • 10.4.11.2. Product Portfolio
      • 10.4.11.3. Financial Overview
      • 10.4.11.4. Business Strategies and Development
    • 10.4.12. Kawasumi Laboratories Inc.
      • 10.4.12.1. Company Overview
      • 10.4.12.2. Product Portfolio
      • 10.4.12.3. Financial Overview
      • 10.4.12.4. Business Strategies and Development
    • 10.4.13. Therakos Incorporation
      • 10.4.13.1. Company Overview
      • 10.4.13.2. Product Portfolio
      • 10.4.13.3. Financial Overview
      • 10.4.13.4. Business Strategies and Development

11. Appendix

  • 11.1. Research Methodology
  • 11.2. Report Assumptions
  • 11.3. Acronyms and Abbreviations